Your browser doesn't support javascript.
loading
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.
Martin, Sophie; Pflumio, Carole; Trensz, Philippe; Schaff-Wendling, Frederique; Weindling, Michal Kalish-; Fischbach, Cathie; Pierard, Laure; Limacher, Jean-Marc; Nader, Rita; Velten, Michel; Petit, Thierry.
Afiliación
  • Martin S; Department of Medical Oncology, Strasbourg Cancer Institute (ICANS), Strasbourg, France. Electronic address: s.martin@icans.eu.
  • Pflumio C; Department of Medical Oncology, Strasbourg Cancer Institute (ICANS), Strasbourg, France.
  • Trensz P; Department of Medical Oncology, Strasbourg Cancer Institute (ICANS), Strasbourg, France.
  • Schaff-Wendling F; Department of Medical Oncology, Clinique de l'Orangerie, Strasbourg, France.
  • Weindling MK; Department of Medical Oncology, Strasbourg Cancer Institute (ICANS), Strasbourg, France.
  • Fischbach C; Department of Medical Oncology, Strasbourg Cancer Institute (ICANS), Strasbourg, France.
  • Pierard L; Department of Medical Oncology, Strasbourg Cancer Institute (ICANS), Strasbourg, France.
  • Limacher JM; Department of Medical Oncology and Clinical Hematology, Hôpital Louis Pasteur, Colmar, France.
  • Nader R; Department of Medical Oncology, Strasbourg Cancer Institute (ICANS), Strasbourg, France.
  • Velten M; Department of Epidemiology and Public Health, Strasbourg University, Inserm, Strasbourg, France; Department of Public Health, ICANS, Strasbourg, France.
  • Petit T; Department of Medical Oncology, Strasbourg Cancer Institute (ICANS), Strasbourg, France.
Clin Breast Cancer ; 23(1): 32-37, 2023 01.
Article en En | MEDLINE | ID: mdl-36414498
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de Proteínas Quinasas / COVID-19 / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de Proteínas Quinasas / COVID-19 / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article